SEC Seal
SEC Banner
Search the Next-Generation EDGAR System
Filing Detail
Form 10-Q/A - Quarterly report [Sections 13 or 15(d)]: [Amend]
SEC Accession No. 0001564590-18-011026
Filing Date
2018-05-04
Accepted
2018-05-04 17:00:15
Documents
3
Period of Report
2018-03-31

Document Format Files

Seq Description Document Type Size
1 10-Q/A sbph-10qa_20180331.htm 10-Q/A 35462
2 EX-31.1 sbph-ex311_6.htm EX-31.1 20632
3 EX-31.2 sbph-ex312_7.htm EX-31.2 20017
  Complete submission text file 0001564590-18-011026.txt   77096
Mailing Address 86 SOUTH STREET HOPKINTON MA 01748
Business Address 86 SOUTH STREET HOPKINTON MA 01748 508-473-5993 X119
Spring Bank Pharmaceuticals, Inc. (Filer) CIK: 0001566373 (see all company filings)

IRS No.: 522386345 | State of Incorp.: DE | Fiscal Year End: 1231
Type: 10-Q/A | Act: 34 | File No.: 001-37718 | Film No.: 18808715
SIC: 2834 Pharmaceutical Preparations